Study Group (Bemiparin +)

Control Group (Bemiparin −)

MTHFR C677T Heterozygote Mutation

46 (71.87%)

36 (64.28%)

MTHFR C677T Homozygote Mutation

18 (28.12%)

20 (35.71%)

Total

64

56